Cargando…

Angiogenesis Inhibitor Bevacizumab Increases the Risk of Ischemic Heart Disease Associated with Chemotherapy: A Meta-Analysis

Concerns have arisen regarding the risk of ischemic heart disease with the novel antiangiogenic agent bevacizumab, a recombinant humanised monoclonal antibody to the vascular endothelial growth factor that is widely used in cancer treatment. Currently, the role of bevacizumab in ischemic heart disea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xing-Lin, Lei, Ying-Hong, Liu, Cun-Fei, Yang, Qun-Fang, Zuo, Pei-Yuan, Liu, Cheng-Yun, Chen, Chang-Zhong, Liu, Yu-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688569/ https://www.ncbi.nlm.nih.gov/pubmed/23818962 http://dx.doi.org/10.1371/journal.pone.0066721

Ejemplares similares

Increased Risk of Cerebrovascular Events in Patients with Cancer Treated with Bevacizumab: A Meta-Analysis
por: Zuo, Pei-Yuan, et al.
Publicado: (2014)

Therapeutic Angiogenesis of Chinese Herbal Medicines in Ischemic Heart Disease: A Review
por: Guo, Dongqing, et al.
Publicado: (2018)

Inhibition of Angiogenesis and Extracellular Matrix Remodeling: Synergistic Effect of Renin-Angiotensin System Inhibitors and Bevacizumab
por: Ren, Tianshu, et al.
Publicado: (2022)

Platelet function is disturbed by the angiogenesis inhibitors sunitinib and sorafenib, but unaffected by bevacizumab
por: Walraven, Maudy, et al.
Publicado: (2018)

Effect of Angiogenesis Inhibitor Bevacizumab on Survival in Patients with Cancer: A Meta-Analysis of the Published Literature
por: Su, Yuan, et al.
Publicado: (2012)

A Novel Angiogenesis Inhibitor Bevacizumab Induces Apoptosis in the Rat Endometriosis Model
por: Soysal, D, et al.
Publicado: (2015)

Dynamics of angiogenesis in ischemic areas of the infarcted heart
por: Kobayashi, Koichi, et al.
Publicado: (2017)

Bevacizumab with preoperative chemotherapy versus preoperative chemotherapy alone for colorectal cancer liver metastases: a retrospective cohort study
por: Lu, Zhen-Hai, et al.
Publicado: (2016)

Neoadjuvant Therapy of Cervical Carcinoma with the Angiogenesis Inhibitor Bevacizumab: a Single-Centre Analysis
por: Junker, Philip, et al.
Publicado: (2018)

A Phase I/II Study Targeting Angiogenesis Using Bevacizumab Combined with Chemotherapy and a Histone Deacetylase Inhibitor (Valproic Acid) in Advanced Sarcomas
por: Monga, Varun, et al.
Publicado: (2018)

PD-1 inhibitor plus chemotherapy versus bevacizumab plus chemotherapy in patients with advanced non-squamous non-small-cell lung cancer: a pooled analysis of three randomised trials
por: Meng, Xiangjiao, et al.
Publicado: (2022)

Efficacy and safety of sintilimab plus bevacizumab in metastatic nasopharyngeal carcinoma after failure of platinum-based chemotherapy: an open-label phase 2 study
por: Lu, Nian, et al.
Publicado: (2023)

Osimertinib Rechallenge With Bevacizumab vs. Chemotherapy Plus Bevacizumab in EGFR-Mutant NSCLC Patients With Osimertinib Resistance
por: Cui, Qingli, et al.
Publicado: (2022)

Endothelial-Specific Molecule 1 Inhibition Lessens Productive Angiogenesis and Tumor Metastasis to Overcome Bevacizumab Resistance
por: Kang, Nannan, et al.
Publicado: (2022)

Therapeutic angiogenesis and tissue revascularization in ischemic vascular disease
por: Chen, Xinyue, et al.
Publicado: (2023)

Inflammation-Mediated Angiogenesis in Ischemic Stroke
por: Zhu, Hua, et al.
Publicado: (2021)

First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for HER2-altered NSCLC: a retrospective real-world POLISH study
por: Yang, Guangjian, et al.
Publicado: (2022)

A novel method of screening combinations of angiostatics identifies bevacizumab and temsirolimus as synergistic inhibitors of glioma-induced angiogenesis
por: Dorrell, Michael I., et al.
Publicado: (2021)

Preoperative bevacizumab does not increase complications following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: King, Bradley H., et al.
Publicado: (2020)

Growth factor for therapeutic angiogenesis in ischemic heart disease: A meta-analysis of randomized controlled trials
por: Tan, Ling, et al.
Publicado: (2022)

Bevacizumab plus chemotherapy for patients with advanced pulmonary adenocarcinoma harboring EGFR mutations
por: Chen, R.-L., et al.
Publicado: (2017)

Effect of PARP Inhibitor Combined with Bevacizumab on Platinum-Resistant Recurrent Ovarian Epithelial Carcinoma
por: Sun, Li, et al.
Publicado: (2022)

Novel specific anti‐ESM1 antibodies overcome tumor bevacizumab resistance by suppressing angiogenesis and metastasis
por: Kang, Nannan, et al.
Publicado: (2023)

Cardiac pericyte reprogramming by MEK inhibition promotes arteriologenesis and angiogenesis of the ischemic heart
por: Avolio, Elisa, et al.
Publicado: (2022)

Therapeutic angiogenesis based on injectable hydrogel for protein delivery in ischemic heart disease
por: Wang, Junke, et al.
Publicado: (2023)

Taurine-Upregulated Gene 1 Attenuates Cerebral Angiogenesis following Ischemic Stroke in Rats
por: Li, Fei, et al.
Publicado: (2022)

Tumor Delivery of Chemotherapy Combined with Inhibitors of Angiogenesis and Vascular Targeting Agents
por: Cesca, Marta, et al.
Publicado: (2013)

Bevacizumab as adjunct to chemotherapy for chemoresistant ovarian cancer
por: Hamilton, Gerhard
Publicado: (2020)

Application of Bevacizumab Combined With Chemotherapy in Patients With Colorectal Cancer and Its Effects on Brain-Gut Peptides, Intestinal Flora, and Oxidative Stress
por: Chen, Chao, et al.
Publicado: (2022)

Successful Treatment of Metastatic Gallbladder Carcinoma with PD-L1 Expression by the Combination of PD-1 Inhibitor Plus Bevacizumab with Chemotherapy: A Case Report
por: Guo, Lihong, et al.
Publicado: (2022)

Low-dosage metronomic chemotherapy and angiogenesis: topoisomerase inhibitors irinotecan and mitoxantrone stimulate VEGF-A-mediated angiogenesis
por: ALBERTSSON, PER, et al.
Publicado: (2012)

MicroRNA-377 Regulates Mesenchymal Stem Cell-Induced Angiogenesis in Ischemic Hearts by Targeting VEGF
por: Wen, Zhili, et al.
Publicado: (2014)

Osteochondral angiogenesis and increased protease inhibitor expression in OA
por: Fransès, R.E., et al.
Publicado: (2010)

Therapeutic angiogenesis of adipose-derived stem cells for ischemic diseases
por: Zhao, Lina, et al.
Publicado: (2017)

Improvement of increased cQTd is associated with heart function in patients with ischemic heart failure
por: Guo, Hui, et al.
Publicado: (2018)

A Novel Combination of Bevacizumab with Chemotherapy Improves Therapeutic Effects for Advanced Biliary Tract Cancer: A Retrospective, Observational Study
por: Pei, Sung-Nan, et al.
Publicado: (2021)

Outcomes of bevacizumab combined with chemotherapy in lung adenocarcinoma‐induced malignant pleural effusion
por: Tao, Hong, et al.
Publicado: (2018)

Ultrasound combined with targeted cationic microbubble-mediated angiogenesis gene transfection improves ischemic heart function
por: Zhou, Qing, et al.
Publicado: (2017)

Genetic Modification of Neurons to Express Bevacizumab for Local Anti-angiogenesis Treatment of Glioblastoma
por: Hicks, Martin J., et al.
Publicado: (2014)

Comparison of Bevacizumab and Aflibercept for Suppression of Angiogenesis in Human Retinal Microvascular Endothelial Cells
por: Yazdanyar, Amirfarbod, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_40ul4e005fndeahnf0kb9v2546